Yahoo
NasdaqCM - Nasdaq Real Time Price USD

SenesTech, Inc. (SNES)

1.0800 +0.0700 (+6.93%)
At close: October 30 at 4:00:01 PM EDT
1.0799 -0.0001 (-0.01%)
After hours: October 30 at 6:35:32 PM EDT
Chart Range Bar
Loading chart for SNES
  • Previous Close 1.0100
  • Open 1.0148
  • Bid 0.5040 x 200
  • Ask 0.8500 x 100
  • Day's Range 0.9600 - 1.0900
  • 52 Week Range 0.5500 - 3.6090
  • Volume 95,314
  • Avg. Volume 1,059,916
  • Market Cap (intraday) 5.728M
  • Beta (5Y Monthly) 0.26
  • PE Ratio (TTM) --
  • EPS (TTM) -1.2200
  • Earnings Date (est.) Nov 9, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 7.50

SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption. It also develops Evolve Mouse, a modified version of its bait technology containing the active ingredient cottonseed oil that limits reproduction of male and female mice. The company was incorporated in 2004 and is headquartered in Surprise, Arizona.

www.senestech.com

23

Full Time Employees

December 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SNES
49.53%
S&P 500 (^GSPC)
10.73%

1-Year Return

SNES
67.76%
S&P 500 (^GSPC)
11.11%

3-Year Return

SNES
97.05%
S&P 500 (^GSPC)
81.91%

5-Year Return

SNES
99.97%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 770k
Earnings -1.83M
Profit Margin -237.92%

Q2

FY25

Q3

FY25

Q4

FY25

Q2

FY26

-2M
-1M
-500K
0
500K
-400.0%
-350.0%
-300.0%
-250.0%
-200.0%

Analyst Insights

View More

Analyst Price Targets

5.00
7.50 Average
1.0800 Current
10.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 12/13/2024
Analyst HC Wainwright & Co.
Rating Action Reiterates
Rating Buy
Price Action Raises
Price Target 3.5 -> 10

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -294.73%

  • Return on Assets (ttm)

    -45.55%

  • Return on Equity (ttm)

    -107.41%

  • Revenue (ttm)

    2.37M

  • Net Income Avi to Common (ttm)

    -7M

  • Diluted EPS (ttm)

    -1.2200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.08M

  • Total Debt/Equity (mrq)

    42.62%

  • Levered Free Cash Flow (ttm)

    -4.36M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: